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Christopher M. Kramer, MD,* Y. Chandrashekhar, MD,y Jagat Narula, MD, PHDzO ne of the major strengths of cardiac mag-netic resonance (CMR) is its ability tocharacterize tissue noninvasively and
quantitatively (1), which facilitates the differential
diagnosis of various cardiac conditions, especially
the cardiomyopathies. Late gadolinium enhancement
(LGE) is the current workhorse, detecting macro-
scopic replacement scars as small as a few hundred
milligrams in size. However, many diseases are asso-
ciated with edema or a ﬁner interstitial ﬁbrosis that
eludes LGE, especially when diffuse. One of the
exciting emerging techniques is the use of T1 map-
ping, and detecting diffuse ﬁbrosis is an area where
pre-contrast and post-contrast T1 mapping adds sig-
niﬁcant value. T1 of the myocardium can be
measured by mapping with a modiﬁed Look-Locker
inversion recovery sequence (2) and shorter breath-
hold versions of this approach (3). Native or pre-
contrast T1, measured before contrast infusion, and
post-contrast T1 can be used to calculate the extracel-
lular volume fraction (ECV) of the myocardium (4). T1
values reﬂect tissue water content, diffuse ﬁbrosis,
and the amount of collagen and can be an accurate
quantitative signature for such pathology. Changes
in T1 values mirror changes in ECV and seem to pro-
vide better insight into tissue than LGE alone. More
important, changes in T1 values correlate with
changes in the pathology and severity of disease (5)
and can even predict outcomes in some conditions,
including diabetes (6) and myocardial infarction (7).
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T1, but some inﬁltrative conditions, such as iron
overload, may reduce it. Prior studies have shown
elevated native T1 in both dilated and hypertrophic
cardiomyopathies (8,9). Amyloidosis characteristi-
cally demonstrates the highest native T1 values (10).
The beauty of native T1 mapping is that it eliminates
the need for gadolinium contrast infusion, which can
be an issue in patients with chronic kidney disease
because of the concern for nephrogenic systemic
ﬁbrosis, and chronic kidney disease is highly preva-
lent in patients with amyloidosis. T1 mapping is there-
fore a versatile technique. It is, however, important to
remember that T1 validation with histology comes
mainly from severe disease. Similarly, there is a
paucity of data on tracking serial changes in T1 as an
index of disease progression or regression. Many
other variables affect T1 values and hence the reli-
ability of measuring T1 accurately, but one of the
strengths of this technique is that a change in T1
may still be a powerful predictor of outcomes when
done in the same laboratory under similar conditions.
CMR approaches have been applied for nearly 2
decades for diagnosing acute or chronic myocarditis.
The so-called early contrast enhancement approach
(11) uses the ratio of post-contrast to pre-contrast
signal in the myocardium to post- to pre-contrast ra-
tio in skeletal muscle. The problem with the early
contrast enhancement approach is that skeletal
muscle inﬂammation can occur in viral syndromes,
which can confound the use of the ratio, and it is not
particularly reproducible. The ﬁnding of LGE in the
midwall and subepicardium of the left ventricle is
typical of myocarditis and has been validated against
histology (12). In addition, T2-weighted imaging of
myocardial edema can be a useful diagnostic sign but
has been replaced by more quantitative T2 mapping
(13). The Lake Louise consortium suggested that
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116positive results on 2 of 3 techniques (early enhance-
ment ratio, LGE, and/or increased T2 signal) might be
the best diagnostic approach (14). Interestingly, 1
recent study using histology as the gold standard
demonstrated that the sensitivity of these 3 tech-
niques for making the diagnosis depended on the
clinical presentation of the patient (15). In infarct-like
presentations, each technique was positive in 70% to
80% of patients, but in cardiomyopathic or arrhy-
thmic presentations, the sensitivity of any of these
techniques was signiﬁcantly lower.
More recently, the development of T1 mapping has
replaced the use of early enhancement ratio, and T2
mapping has superseded qualitative assessment of T2
from black-blood or white-blood T2-weighted imag-
ing pulse sequences. Previous studies published in
iJACC have documented the utility of native T1
mapping in myocarditis. Ferreira et al. (16) studied 50
patients with suspected acute myocarditis and 45
age-matched controls and showed that patients had
higher T2 signal intensity ratios and native myocar-
dial T1 than controls. In fact, a T1 cutoff of 990 ms at
1.5-T demonstrated sensitivity, speciﬁcity, and diag-
nostic accuracy of 90%, 91%, and 91%, respectively. A
combination of these techniques may be the best
method of accurately identifying acute myocarditis.
In 1 recent study of 104 patients and 21 controls, a
stepwise approach using LGE and myocardial ECV
>27% (as measured using pre- and post-contrast T1
mapping) demonstrated an overall accuracy of 90%
(17). CMR has clearly been good at detecting myo-
carditis, but there are few modalities that are good at
tracking the acuity and progress of the disease. Serial
T1 mapping pre- and post-contrast, along with
measuring ECV, might provide information over and
above that obtained from LGE alone.
In this issue of iJACC, Hinojar et al. (18) report their
results in 165 patients with the clinical diagnosis of
myocarditis at either 1.5- or 3.0-T using native and
post-contrast T1 mapping, T2-weighted imaging, and
LGE. Sixty-one of the patients had acute and 67 had
chronic myocarditis, whereas another 37 patients had
serial studies. Native T1 was higher in patients with
acute than chronic disease and performed better than
T2-weighted imaging and LGE at making an accuratediagnosis. For acute myocarditis, the diagnostic ac-
curacy of native T1 was 99%, compared with 86% for
LGE alone and 72% for increased T2-weighted signal.
In chronic myocarditis, LGE alone performed better
than T1 mapping (94% vs. 84% accuracy), but the
combination of the 2 techniques performed even
better, with 98% overall accuracy. The investigators
established cutoffs for native T1 values to discrimi-
nate acute versus chronic myocarditis (>5 SD above
normal for acute and >2 SD above normal for chronic).
Although previous studies had established the
utility of T1 mapping in myocarditis (16,17), this study
adds information about cutoff values and clearly
demonstrates the steady decline in native T1 as the
inﬂammation of acute myocarditis resolves and the
myocardium heals into the convalescent phase. There
are a few limitations to the study. One is that only 1
mid-ventricular slice was imaged with T1 mapping. It
is somewhat surprising that T1 mapping performed so
well with such limited sampling given the patchy
myocardial involvement in myocarditis. Second, the
post-contrast data are presented as l rather than the
more accepted measure of ECV (4). This is likely
because a measure of hematocrit is needed to calcu-
late ECV, and perhaps the investigators did not have
this value in a sufﬁcient number of patients. It would
have been useful to compare native T1 with ECV in
diagnostic accuracy, especially given the data of
Radunski et al. (17) discussed previously. Last, T1
mapping is vendor and scanner speciﬁc, so that the
values published in the present paper cannot be
universally applied. Each site and scanner would
need to establish their own normal values.
In summary, as evidenced by the present paper,
tissue characterization with CMR is progressively
being reﬁned with the development of improved
quantitation (T1 and T2 mapping) and the establish-
ment of cutoff values for the diagnosis of disease at
different ﬁeld strengths. The era of the noninvasive
myocardial biopsy (19), therefore continues to evolve.
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